These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 27813099)

  • 41. Letter to the editor in response to Akita et al. 2020.
    Seligmann G; Ponnampalam J; Pimento D; Little C
    Eur Heart J Cardiovasc Pharmacother; 2021 May; 7(3):e52. PubMed ID: 32991695
    [No Abstract]   [Full Text] [Related]  

  • 42. Letter to the Editor in Response to Tzikas et al. 2020.
    Patel R; Liebert C; Kirresh A; Ahmad M
    Eur Heart J Cardiovasc Pharmacother; 2021 May; 7(3):e14-e15. PubMed ID: 32614414
    [No Abstract]   [Full Text] [Related]  

  • 43. Response to Letter to the Editor by Coyner et al.
    McClintock DE; Austel M; Banovic F
    Vet Dermatol; 2022 Apr; 33(2):181-182. PubMed ID: 35312107
    [No Abstract]   [Full Text] [Related]  

  • 44. Letter to the editor: response to Morrison
    Ni Eochagain A
    Reg Anesth Pain Med; 2022 Jun; 47(6):386-387. PubMed ID: 35273071
    [No Abstract]   [Full Text] [Related]  

  • 45. Response to the Letter to the Editor by Kishore et al.
    Biousse V; Newman NJ
    J Stroke Cerebrovasc Dis; 2022 May; 31(5):106403. PubMed ID: 35227569
    [No Abstract]   [Full Text] [Related]  

  • 46. Letter to the Editor in response to Bygdell et al.
    Ademiju O
    Eur J Prev Cardiol; 2022 Jul; 29(9):e289. PubMed ID: 35403196
    [No Abstract]   [Full Text] [Related]  

  • 47. Response to the letter to the editor from Dupouy-Camet et al.
    Xiong Z; Shen Y; Li Z; Hu X; Hu D
    Abdom Radiol (NY); 2022 Oct; 47(10):3640-3641. PubMed ID: 35798963
    [No Abstract]   [Full Text] [Related]  

  • 48. Letter to the editor in response to Kobo et al. 2022.
    Kageyama S; Serruys PW; Onuma Y; Garg S
    Eur Heart J Qual Care Clin Outcomes; 2022 Nov; 8(8):919-920. PubMed ID: 35983776
    [No Abstract]   [Full Text] [Related]  

  • 49. Letter to the editor in response to Sengupta et al. (2022).
    Aboutorabi M; Ahmad M; Bray JJH
    Eur Heart J Qual Care Clin Outcomes; 2022 Oct; 8(7):798. PubMed ID: 35671115
    [No Abstract]   [Full Text] [Related]  

  • 50. Response to "Letter to the Editor" by Couret et al.
    Ong C
    Neurocrit Care; 2019 Apr; 30(2):494. PubMed ID: 30644038
    [No Abstract]   [Full Text] [Related]  

  • 51. Response to the Letter to the Editor by Mungmunpuntipantip et al.
    Stamenković M; Radmilo L; Jovićević M; Rabi-Žikić T; Žarkov M; Ružička-Kaloci S; Simić S; Stamenković A; Dangić J; Knezović G; Živanović Ž
    J Stroke Cerebrovasc Dis; 2022 Aug; 31(8):106558. PubMed ID: 35691764
    [No Abstract]   [Full Text] [Related]  

  • 52. Response to the letter to the editor by Mulia et al.
    Matsumura M; Sotomi Y; Higuchi Y
    Heart Vessels; 2023 Jun; 38(6):876-877. PubMed ID: 36048203
    [No Abstract]   [Full Text] [Related]  

  • 53. Response to Letter to the Editor, Gilks et al.
    Weigelt B; Mueller JJ; Ellenson LH; Abu-Rustum NR; Aghajanian C
    Gynecol Oncol; 2023 Sep; 176():181-182. PubMed ID: 37438207
    [No Abstract]   [Full Text] [Related]  

  • 54. Response to Letter to the Editor from deKemp, et al.
    Poitrasson-Rivière A; Murthy VL
    J Nucl Cardiol; 2021 Jun; 28(3):859-862. PubMed ID: 33851352
    [No Abstract]   [Full Text] [Related]  

  • 55. Letter to the Editor in Response to Sengupta et al. (2022).
    Aboutorabi M; Ahmad M; Bray JJH
    Eur Heart J Qual Care Clin Outcomes; 2024 Jan; 10(1):104. PubMed ID: 37312271
    [No Abstract]   [Full Text] [Related]  

  • 56. Response to the Letter to the Editor by Cioccari et al.
    Konwinski LM; Steenland C; Miller K; Boville B; Fitzgerald R; Connors R; Sterling EK; Stowe A; Rajasekaran S
    J Patient Saf; 2024 Jul; ():. PubMed ID: 39037322
    [No Abstract]   [Full Text] [Related]  

  • 57. Response to Letter to the Editor by Goupell et al.
    Aronoff JM; Staisloff HE
    Ear Hear; 2024 Mar-Apr 01; 45(2):527-528. PubMed ID: 38372760
    [No Abstract]   [Full Text] [Related]  

  • 58. Letter to the editor in response to Chan et al. 2023.
    Thompson SE; Ahmad M
    Eur Heart J Cardiovasc Pharmacother; 2024 Jul; 10(4):364. PubMed ID: 38271609
    [No Abstract]   [Full Text] [Related]  

  • 59. Response to Letter to the Editor From Nunez et al.
    DeMik DE; Carender CN; Bedard NA; Glass NA; Callaghan JJ; Brown TS
    J Arthroplasty; 2023 Feb; 38(2):e2. PubMed ID: 36608989
    [No Abstract]   [Full Text] [Related]  

  • 60. Letter to the editor in response to Komen et al. 2021.
    Kumar NS; Ahmed M
    Eur Heart J Cardiovasc Pharmacother; 2021 May; 7(3):e26. PubMed ID: 33711153
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.